Clostridium difficile Infection (CDI) in Solid Organ and Hematopoietic Stem Cell Transplant Recipients

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Current Infectious Disease Reports

• Publication date

  2014-06-04

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s11908-014-0414-0PMID 24893981
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• C. difficile Infection: Changing Epidemiology and Management Paradigms

  2015cited by this paper
• Human Microbiota Characterization in the Course of Renal Transplantation

  2014cited by this paper
• NAP1 strain type predicts outcomes from Clostridium difficile infection.

  2014cited by this paper
• Fecal Microbiota Transplantation for Refractory Clostridium difficile Colitis in Solid Organ Transplant Recipients

  2014cited by this paper
• Early Clostridium difficile Infection during Allogeneic Hematopoietic Stem Cell Transplantation

  2014cited by this paper
• A retrospective review of metronidazole and vancomycin in the management of Clostridium difficile infection in patients with hematologic malignancies

  2014cited by this paper
• Estimating Risk of C. difficile Transmission from PCR Positive but Cytotoxin Negative Cases

  2014cited by this paper
• Clostridium difficile infection in patients with acute myelogenous leukemia and in patients undergoing allogeneic stem cell transplantation: epidemiology and risk factor analysis.

  2014cited by this paper
• Microbes and Allogeneic Transplantation

  2014cited by this paper
• Changing epidemiology of Clostridium difficile-associated disease during stem cell transplantation.

  2013cited by this paper
• Advanced techniques for detection and identification of microbial agents of gastroenteritis.

  2013cited by this paper
• Clostridium difficile infection after adult autologous stem cell transplantation: a multicenter study of epidemiology and risk factors.

  2013cited by this paper
• Fidaxomicin versus Conventional Antimicrobial Therapy in 59 Recipients of Solid Organ and Hematopoietic Stem Cell Transplantation with Clostridium difficile-Associated Diarrhea

  2013cited by this paper
• Clostridium difficile infection increases mortality risk in lung transplant recipients.

  2013cited by this paper
• Comparison of Illumigene, Simplexa, and AmpliVue Clostridium difficile Molecular Assays for Diagnosis of C. difficile Infection

  2013cited by this paper
• Clostridium difficile Infections in Solid Organ Transplantation

  2013cited by this paper
• Use of multilocus variable number of tandem repeats analysis genotyping to determine the role of asymptomatic carriers in Clostridium difficile transmission.

  2013cited by this paper
• Risk factors associated with Clostridium difficile infection after kidney and pancreas transplantation

  2013cited by this paper
• Multicenter Evaluation of the Verigene Clostridium difficile Nucleic Acid Assay

  2013cited by this paper
• Clostridium difficile Infection and Limitations of Markers for Severity in Patients with Hematologic Malignancy

  2013cited by this paper
• Resolution of Clostridium difficile-associated diarrhea in patients with cancer treated with fidaxomicin or vancomycin.

  2013cited by this paper
• Prospective Evaluation Of Risk Factors For Clostridium Difficile Colonization Among Allogenic Hematopoietic Stem Cell Transplant Recipients, 2010-2012

  2013cited by this paper
• Image of the month: “butterfly” effect, or mirror image, caused by a coiled esophageal manometry catheter.

  2013cited by this paper
• Epidemiology, risk factors, and outcomes of Clostridium difficile infection in kidney transplant recipients

  2013cited by this paper
• Correlation between Clostridium difficile Bacterial Load, Commercial Real-Time PCR Cycle Thresholds, and Results of Diagnostic Tests Based on Enzyme Immunoassay and Cell Culture Cytotoxicity Assay

  2013cited by this paper
• Evaluation of Luminex xTAG Gastrointestinal Pathogen Analyte-Specific Reagents for High-Throughput, Simultaneous Detection of Bacteria, Viruses, and Parasites of Clinical and Public Health Importance

  2013cited by this paper
• Impact of the type of diagnostic assay on Clostridium difficile infection and complication rates in a mandatory reporting program.

  2013cited by this paper
• Guidelines for Diagnosis, Treatment, and Prevention of Clostridium difficile Infections

  2013cited by this paper
• The rise of Clostridium difficile infection in lung transplant recipients in the modern era

  2013cited by this paper
• Clostridium difficile infection among hematopoietic stem cell transplant recipients: beyond colitis

  2013cited by this paper
• Diverse sources of C. difficile infection identified on whole-genome sequencing.

  2013cited by this paper
• OPINION Clostridium difficile infection among hematopoietic stem cell transplant recipients: beyond colitis

  2013cited by this paper
• Evaluation of a New Molecular Test, the BD Max Cdiff, for Detection of Toxigenic Clostridium difficile in Fecal Samples

  2012cited by this paper
• Clostridium difficile infection in hospitalized liver transplant patients: A nationwide analysis

  2012cited by this paper
• Clostridium Difficile Colitis: Increasing Incidence, Risk Factors, and Outcomes in Solid Organ Transplant Recipients

  2012cited by this paper
• Outcome of Clostridium difficile‐associated disease in solid organ transplant recipients: a prospective and multicentre cohort study

  2012cited by this paper
• Vital signs: preventing Clostridium difficile infections.

  2012cited by this paper
• Multicenter Clinical Evaluation of the Portrait Toxigenic C. difficile Assay for Detection of Toxigenic Clostridium difficile Strains in Clinical Stool Specimens

  2012cited by this paper
• Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation.

  2012cited by this paper
• Association of Clostridium difficile infection with outcomes of hospitalized solid organ transplant recipients: results from the 2009 Nationwide Inpatient Sample database

  2012cited by this paper
• Epidemiology and outcomes of Clostridium difficile infections in hematopoietic stem cell transplant recipients.

  2012cited by this paper
• Clostridium difficile infection after allogeneic hematopoietic stem cell transplantation: incidence, risk factors, and outcome.

  2012cited by this paper
• Regulation of intestinal inflammation by microbiota following allogeneic bone marrow transplantation

  2012cited by this paper
• Interaction between the intestinal microbiota and host in Clostridium difficile colonization resistance.

  2012cited by this paper
• Characterisation of Clostridium difficile Hospital Ward–Based Transmission Using Extensive Epidemiological Data and Molecular Typing

  2012cited by this paper
• Hospital-Onset Clostridium difficile Infection Rates in Persons with Cancer or Hematopoietic Stem Cell Transplant: A C3IC Network Report

  2012cited by this paper
• Impact of PCR Testing for Clostridium difficile on Incident Rates and Potential on Public Reporting: Is the Playing Field Level?

  2011cited by this paper
• Evaluation of a Loop-Mediated Isothermal Amplification Assay for Diagnosis of Clostridium difficile Infections

  2011cited by this paper
• Busulfan and Metronidazole: An Often Forgotten but Significant Drug Interaction

  2011cited by this paper
• Clostridium difficile‐related pancolitis in lung‐transplanted patients with cystic fibrosis

  2011cited by this paper
• Recent epidemiology of Clostridium difficile infection during hematopoietic stem cell transplantation

  2011cited by this paper
• Clinical practice guidelines for Clostridium difficile infection in adults:2010 update by the Society for Healthcare Epidemiology of America(SHEA)and the Infectious Diseases Society of America(IDSA)

  2011cited by this paper
• Evaluation of the Cepheid Xpert Clostridium difficile Epi Assay for Diagnosis of Clostridium difficile Infection and Typing of the NAP1 Strain at a Cancer Hospital

  2010cited by this paper
• Clostridium difficile Is Associated With Poor Outcomes in Patients With Cirrhosis: A National and Tertiary Center Perspective

  2010cited by this paper
• Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)

  2010cited by this paper
• Outcomes of patients who develop symptomatic Clostridium difficile infection after solid organ transplantation.

  2010cited by this paper
• Fulminant Clostridium difficile Colitis in a Post-Liver Transplant Patient

  2010cited by this paper
• Treatment with monoclonal antibodies against Clostridium difficile toxins.

  2010cited by this paper
• Clostridium difficile colitis in children following lung transplantation

  2010cited by this paper
• Rifaximin for the treatment of recurrent Clostridium difficile infection after liver transplantation: A case series

  2010cited by this paper
• Incidence of Clostridium difficile Infection in Patients with Acute Leukemia and Lymphoma after Allogeneic Hematopoietic Stem Cell Transplantation

  2010cited by this paper
• The Role of Intestinal Microbiota in the Development and Severity of Chemotherapy-Induced Mucositis

  2010cited by this paper
• European Society of Clinical Microbiology and Infectious Diseases (ESCMID): treatment guidance document for Clostridium difficile infection (CDI).

  2009cited by this paper
• Systemic absorption of oral vancomycin in a peripheral blood stem cell transplant patient with severe graft‐versus‐host disease of the gastrointestinal tract

  2009cited by this paper
• Recurrent Clostridium difficile infection: a review of risk factors, treatments, and outcomes.

  2009cited by this paper
• Clostridium difficile infection: new developments in epidemiology and pathogenesis

  2009cited by this paper
• Clostridium difficile colitis in lung transplantation

  2008cited by this paper
• Clostridium difficile colitis in cystic fibrosis patients with and without lung transplantation

  2008cited by this paper
• Early and late onset Clostridium difficile‐associated colitis following liver transplantation

  2007cited by this paper
• Clostridium difficile-associated diarrhea in heart transplant recipients: is hypogammaglobulinemia the answer?

  2007cited by this paper
• Clostridium difficile-associated diarrhea after living donor liver transplantation.

  2007cited by this paper
• Clostridium difficile Colitis in Solid Organ Transplantation—A Single-Center Experience

  2007cited by this paper
• A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity.

  2007cited by this paper
• Severity of Clostridium difficile–Associated Disease (CDAD) in Allogeneic Stem Cell Transplant Recipients: Evaluation of a CDAD Severity Grading System

  2007cited by this paper
• Outcome of metronidazole therapy for Clostridium difficile disease and correlation with a scoring system.

  2007cited by this paper
• Incidence of Clostridium difficile-associated diarrhea before and after autologous peripheral blood stem cell transplantation for lymphoma and multiple myeloma

  2006cited by this paper
• Diseases and drug-related interventions affecting host defence

  2006cited by this paper
• Decreased levels of serum immunoglobulins as a risk factor for infection after heart transplantation.

  2005cited by this paper
• A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality.

  2005cited by this paper
• Infectious Enteritis After Intestinal Transplantation: Incidence, Timing, and Outcome

  2005cited by this paper
• Infectious enteritis after intestinal transplantation: incidence, timing, and outcome.

  2004cited by this paper
• Severe elevations of FK506 blood concentration due to diarrhea in renal transplant recipients

  2004cited by this paper
• Clostridium difficile colitis

  2004cited by this paper
• Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity

  2004cited by this paper
• Clostridium difficile colitis in patients after kidney and pancreas–kidney transplantation

  2004cited by this paper
• The effect of metronidazole on busulfan pharmacokinetics in patients undergoing hematopoietic stem cell transplantation

  2003cited by this paper
• Fulminant Clostridium difficile: An Underappreciated and Increasing Cause of Death and Complications

  2002cited by this paper
• Hypogammaglobulinemia following cardiac transplantation: a link between rejection and infection.

  2001cited by this paper
• Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea.

  2001cited by this paper
• Significant post‐transplant hypogammaglobulinemia in six heart transplant recipients: an emerging clinical phenomenon?

  2000cited by this paper
• Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A.

  2000cited by this paper
• Incidence and outcome of Clostridium difficile infection following autologous peripheral blood stem cell transplantation

  1999cited by this paper
• Clostridium difficile colitis.

  1994cited by this paper
• Diseases and drug-related interventions affecting host defence.

  1993cited by this paper

• Effectiveness and Safety of Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection in Immunocompromised Patients.

  2025cites this paper
• Japanese Clinical Practice Guidelines for Management of Clostridioides (Clostridium) difficile infection.

  2022cites this paper
• Gut microbiome in multiple myeloma: Mechanisms of progression and clinical applications

  2022cites this paper
• Clostridioides difficile Diarrhea: An Emerging Problem in a South Indian Tertiary Care Hospital

  2021cites this paper
• Clostridium difficile Infection

  2021cites this paper
• Infection with Clostridioides difficile ribotype 046 in a paediatric liver transplant patient

  2021cites this paper
• Clostridium Difficile infections in patients with AML or MDS undergoing allogeneic hematopoietic stem cell transplantation identify high risk for adverse outcome

  2019cites this paper
• Clinical Review on the Utility of Fecal Microbiota Transplantation in Immunocompromised Patients

  2019cites this paper
• High prevalence of subclass-specific binding and neutralizing antibodies against Clostridium difficile toxins in adult cystic fibrosis sera: possible mode of immunoprotection against symptomatic C. difficile infection. Clinical and Experimental Gastroenterology,

  2018cites this paper
• Clostridium difficile infection is associated with graft loss in solid organ transplant recipients

  2018cites this paper
• Microbiome alterations following solid-organ transplantation: consequences, solutions, and prevention

  2018cites this paper
• Fecal microbiota transplantation for recurrent Clostridium difficile infection in patients with solid organ transplants: an institutional experience and review of the literature

  2018cites this paper
• A Systematic Review of the Efficacy and Safety of Fecal Microbiota Transplant for Clostridium difficile Infection in Immunocompromised Patients

  2018cites this paper
• A multicenter, retrospective, case‐cohort study of the epidemiology and risk factors for Clostridium difficile infection among cord blood transplant recipients

  2017cites this paper
• High prevalence of subclass-specific binding and neutralizing antibodies against Clostridium difficile toxins in adult cystic fibrosis sera: possible mode of immunoprotection against symptomatic C. difficile infection

  2017cites this paper
• Risk factors for the development of Clostridium difficile infection in adult allogeneic hematopoietic stem cell transplant recipients: A single‐center study in Québec, Canada

  2017cites this paper
• Point-Counterpoint: What Is the Optimal Approach for Detection of Clostridium difficile Infection?

  2017cites this paper
• Selected Topics in Anaerobic Bacteriology

  2016cites this paper
• Antibiotics in Hematopoietic Cell Transplantation: Adversaries or Allies?

  2016influential citation
• Clostridium difficile Infections amongst Patients with Haematological Malignancies: A Data Linkage Study

  2016cites this paper
• Laboratory Diagnosis of Infections in Cancer Patients: Challenges and Opportunities

  2016cites this paper
• Fecal microbiota transplantation in patients with cancer undergoing treatment.

  2015cites this paper
• Infectious Diseases in Cancer Patients: An Overview

  2015cites this paper
• Long-Term Follow-Up of Fecal Microbiota Transplantation for Treatment of Recurrent Clostridium difficile Infection in a Dual Solid Organ Transplant Recipient

  2015cites this paper
• Transmission of Clostridium difficile During Hospitalization for Allogeneic Stem Cell Transplant

  2015cites this paper
• Acute graft-versus-host disease, invasive aspergillosis and Clostridium difficile colitis after peripheral blood stem cell transplantation: A complex network of causalities and a challenge for prevention.

  2015cites this paper
• Fecal microbiota transplantation (FMT) for Clostridium difficile infection: focus on immunocompromised patients.

  2015cites this paper